<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01142076</url>
  </required_header>
  <id_info>
    <org_study_id>19850701</org_study_id>
    <nct_id>NCT01142076</nct_id>
  </id_info>
  <brief_title>Xinju Xiaogao Prescription Study on Overweight</brief_title>
  <acronym>XJXG</acronym>
  <official_title>Xinju Xiaogao Prescription and 10% of it in the Treatment of Adiposity (Stagnation of QI Causing Phlegm Retention)Clinical Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Guang'anmen Hospital of China Academy of Chinese Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>China-Japan Friendship Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Affiliated Hospital of the Chinese Academy of Military Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Guang'anmen Hospital of China Academy of Chinese Medical Sciences</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Xinju Xiaogao prescription and 10% of it in the treatment of adiposity (stagnation of QI
      causing phlegm retention)clinical study
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Charged by the three research centers in line with traditional Chinese medicine stagnation of
      QI causing phlegm retention 120 cases have diabetes were randomly divided into Chinese herbal
      compound Xinju Xiaogao prescription group and 10% of the prescription group.The treatment
      groups were compared 24-week step-down and regulation of body weight,waistline, blood lipids,
      blood sugar effect.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2010</start_date>
  <completion_date type="Actual">March 2011</completion_date>
  <primary_completion_date type="Actual">February 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>waistline</measure>
    <time_frame>up to 24 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Body Mass Index (BMI)</measure>
    <time_frame>up to 24 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">140</enrollment>
  <condition>Overweight</condition>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Dose treatment group, 10%</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Xinju Xiaogao Prescription</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>treatment group</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Xinju Xiaogao Prescription</intervention_name>
    <description>treatment group</description>
    <arm_group_label>Xinju Xiaogao Prescription</arm_group_label>
    <other_name>Xinju Xiaogao decoction</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>Therapeutic dose of 10%</description>
    <arm_group_label>placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Aged 18-60 years old

          -  BMI≥28kg/m2，but＜40kg/m2

          -  Waistline≥85cm（male）,≥80cm（female）

          -  Pathoglycemia must fulfill one of those four condition:

          -  IGT,7.8≤2hPG≤11.0mmol/,

          -  diabetics take medicine used to treat type 2 diabetes more than 3 month,and
             5.6≤FBG≤12.2,and weight change under 4kg.

          -  stagnation of QI causing phlegm retention

          -  To sign informed consent.

        Exclusion Criteria:

          -  After 3-6 months simply controlling their diet and more exercise treatment, body
             weight weight loss ≥ 5%.

          -  TG＞4.5mmol/L.

          -  Suffering from congenital heart disease, rheumatic heart disease, kidney disease,
             serious active liver disease, peptic ulcer disease or malabsorption syndrome.

          -  There is a history of pancreatitis or endocrine diseases other than diabetes, diabetes
             treated with insulin.

          -  Not suffered myocardial infarction in Past 3 months or unstable angina were confirmed.

          -  Had been diagnosed as &quot;post-surgical adhesions&quot; .

          -  There is a history of appetite or abuse of laxatives

          -  Diastolic blood pressure,uncontrolled or controlled, three times greater than 105mmHg
             .

          -  Pregnancy, prepare to pregnant or lactating women prepare.

          -  Allergies to Chinese medicine , allergic.

          -  Recurrent gallstone or a history of kidney stones.

          -  Mentally ill.

          -  Cancer patients.

          -  A history of gastrointestinal surgery to lose weight.

          -  Receiving other clinical studies nearly 3 months.

          -  Alcohol and / or psychoactive substances, drug abusers and addicts.

          -  Taking other weight-reducing aid Close within one month
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fenglian Li, PHD</last_name>
    <role>Study Director</role>
    <affiliation>Guang'anmen Hospital of China Academy of Chinese Medical Sciences</affiliation>
  </overall_official>
  <verification_date>December 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 24, 2010</study_first_submitted>
  <study_first_submitted_qc>June 10, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 11, 2010</study_first_posted>
  <last_update_submitted>December 10, 2013</last_update_submitted>
  <last_update_submitted_qc>December 10, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 11, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Guang'anmen Hospital of China Academy of Chinese Medical Sciences</investigator_affiliation>
    <investigator_full_name>Fengmei Lian</investigator_full_name>
    <investigator_title>chief</investigator_title>
  </responsible_party>
  <keyword>adiposity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Overweight</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

